Is DBV Technologies S.A. (DBVT) a Buy, Sell, or Hold?
NASDAQ : DBVT
DBV Technologies S.A.
$15.5676 USD
-$0.14 (-0.91%)
- Volume
- 87.2K
- Average Volume
- 250.86K
- Market Capitalization
- $372.4M
- P/E Ratio
- -3.31
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $26.19
- Year Low
- $8.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.76
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
9
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
8
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$28.38M
DBVT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DBVT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lee Philina | 2025-10-30 | 0 | 2026-04-16 | ||
| Mohideen Pharis | officer: Chief Medical Officer | 2026-01-29 | S-Sale | 4.86 | 2026-02-02 |
| BAKER BROS. ADVISORS LP | director | 2026-01-12 | M-Exempt | 0 | 2026-01-14 |
| BAKER BROS. ADVISORS LP | director | 2026-01-12 | M-Exempt | 0 | 2026-01-14 |
| BAKER BROS. ADVISORS LP | director | 2026-01-12 | M-Exempt | 0 | 2026-01-14 |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-12-17 | S-Sale | 4.84 | 2025-12-19 |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-12-17 | S-Sale | 5.28 | 2025-12-19 |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-12-18 | S-Sale | 4.19 | 2025-12-19 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-11-21 | A-Award | 2.9 | 2025-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-11-21 | A-Award | 0 | 2025-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-11-20 | S-Sale | 2.88 | 2025-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-11-21 | S-Sale | 2.77 | 2025-11-25 |
| Boucinha Virginie | officer: Chief Financial Officer | 2025-11-21 | A-Award | 2.9 | 2025-11-24 |
| Boucinha Virginie | officer: Chief Financial Officer | 2025-11-21 | A-Award | 0 | 2025-11-24 |
| Trapp Kevin Michael | officer: Chief Commercial Officer | 2025-11-21 | A-Award | 2.9 | 2025-11-24 |
| Trapp Kevin Michael | officer: Chief Commercial Officer | 2025-11-21 | A-Award | 0 | 2025-11-24 |
| Tasse Daniel | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-21 | A-Award | 2.9 | 2025-11-24 |
| Trapp Kevin Michael | 2025-11-03 | 0 | 2025-11-12 | ||
| Mohideen Pharis | officer: Chief Medical Officer | 2025-07-29 | S-Sale | 2.22 | 2025-07-31 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-05-22 | S-Sale | 1.84 | 2025-05-27 |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-03-27 | 0 | 2025-05-20 | |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-03-27 | 0 | 2025-05-20 | |
| EPIC Bpifrance | other: Member of 10% owner group | 2025-04-07 | 0 | 2025-05-20 | |
| Bpifrance Investissement S.A.S. | other: Member of 10% owner group | 2025-03-27 | 0 | 2025-04-24 | |
| Bpifrance SA | 10 percent owner | 2025-03-27 | 0 | 2025-04-07 | |
| Bpifrance SA | 10 percent owner | 2025-03-27 | 0 | 2025-04-07 | |
| Bpifrance SA | 10 percent owner | 2025-04-07 | 0 | 2025-04-07 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-27 | A-Award | 0 | 2025-03-31 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-27 | A-Award | 0 | 2025-03-31 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-27 | A-Award | 0 | 2025-03-31 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2025-03-27 | A-Award | 0 | 2025-03-31 |
| Mohideen Pharis | officer: Chief Medical Officer | 2025-01-30 | S-Sale | 0.85 | 2025-01-31 |
| Tasse Daniel | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-04 | A-Award | 0.89 | 2024-12-05 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-11-22 | S-Sale | 0.53 | 2024-11-27 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-11-25 | S-Sale | 0.57 | 2024-11-27 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-11-21 | A-Award | 0.75 | 2024-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-11-21 | A-Award | 0 | 2024-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-11-21 | S-Sale | 0.54 | 2024-11-25 |
| Boucinha Virginie | officer: Chief Financial Officer | 2024-11-21 | A-Award | 0.75 | 2024-11-25 |
| Boucinha Virginie | officer: Chief Financial Officer | 2024-11-21 | A-Award | 0 | 2024-11-25 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-07-29 | S-Sale | 0.98 | 2024-07-31 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-05-22 | S-Sale | 1.38 | 2024-05-29 |
| Mohideen Pharis | officer: Chief Medical Officer | 2024-05-24 | S-Sale | 1.36 | 2024-05-29 |
| Tasse Daniel | director, officer: CHIEF EXECUTIVE OFFICER | 2024-03-08 | P-Purchase | 0.83 | 2024-03-11 |
| Ndu Adora | director | 2024-02-06 | P-Purchase | 0.89 | 2024-02-08 |
| Mohideen Pharis | officer: Chief Medical Officer | 2023-11-22 | S-Sale | 1.74 | 2023-12-19 |
| Boucinha Virginie | officer: Chief Financial Officer | 2023-11-20 | A-Award | 2.19 | 2023-11-22 |
| Boucinha Virginie | officer: Chief Financial Officer | 2023-11-20 | A-Award | 0 | 2023-11-22 |
| Tasse Daniel | director, officer: Chief Executive Officer | 2023-11-20 | A-Award | 2.19 | 2023-11-22 |
| Mohideen Pharis | officer: Chief Medical Officer | 2023-11-20 | A-Award | 2.19 | 2023-11-22 |
| Mohideen Pharis | officer: Chief Medical Officer | 2023-11-20 | A-Award | 0 | 2023-11-22 |
| Boucinha Virginie | officer | 2023-11-06 | 0 | 2023-11-07 | |
| MORRIS TIMOTHY E | director | 2023-08-25 | P-Purchase | 1.52 | 2023-08-28 |
| Tasse Daniel | director, officer: Chief Executive Officer | 2022-11-21 | A-Award | 3.07 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2022-11-21 | A-Award | 3.07 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2022-07-29 | A-Award | 4.83 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2022-11-21 | A-Award | 0 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2022-11-24 | S-Sale | 2.88 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2023-05-24 | S-Sale | 3.54 | 2023-08-14 |
| Mohideen Pharis | officer: Chief Medical Officer | 2022-07-29 | A-Award | 0 | 2023-08-14 |
| Robitaille Sebastien | officer: Chief Financial Officer | 2022-11-21 | A-Award | 3.07 | 2023-08-14 |
| Robitaille Sebastien | officer: Chief Financial Officer | 2022-11-21 | A-Award | 0 | 2023-08-14 |
| SOLAND DANIEL B | director | 2023-08-01 | P-Purchase | 1.62 | 2023-08-03 |
| Guyot-Caparros Daniele | director: | 2022-10-03 | 0 | 2022-10-06 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2022-06-13 | A-Award | 0 | 2022-06-13 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2022-06-13 | A-Award | 0 | 2022-06-13 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2022-06-13 | A-Award | 0 | 2022-06-13 |
| Baker Brothers Life Sciences LP | director: | 2022-06-13 | A-Award | 0 | 2022-06-13 |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2022-06-13 | A-Award | 0 | 2022-06-13 |
| Tasse Daniel | director, officer: Chief Executive Officer | 2021-11-22 | A-Award | 6.62 | 2021-11-24 |
| Mohideen Pharis | officer: Chief Medical Officer | 2021-11-22 | A-Award | 6.62 | 2021-11-24 |
| Mohideen Pharis | officer: Chief Medical Officer | 2021-11-22 | A-Award | 0 | 2021-11-24 |
| Robitaille Sebastien | officer: Chief Financial Officer | 2021-11-22 | A-Award | 6.62 | 2021-11-24 |
| Robitaille Sebastien | officer: Chief Financial Officer | 2021-11-22 | A-Award | 0 | 2021-11-24 |
| SOLAND DANIEL B | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| Ndu Adora | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| MORRIS TIMOTHY E | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| Monges Viviane | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| DE ROSEN MICHEL | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| Rao Madduri Ravin | director | 2021-06-10 | P-Purchase | 13.09 | 2021-06-11 |
| Rao Madduri Ravin | director: | 2021-05-19 | 0 | 2021-06-01 | |
| Ndu Adora | director: | 2021-05-19 | 0 | 2021-06-01 | |
| MORRIS TIMOTHY E | director: | 2021-03-30 | 0 | 2021-04-02 | |
| DE ROSEN MICHEL | director | 2021-01-01 | 0 | 2021-01-12 | |
| DE ROSEN MICHEL | director | 2018-06-28 | 45.54 | 2021-01-12 | |
| GOLLER MICHAEL | director: | 2021-01-01 | 0 | 2021-01-11 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2021-01-01 | 0 | 2021-01-11 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2021-01-01 | 0 | 2021-01-11 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2021-01-01 | 0 | 2021-01-11 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2021-01-01 | 0 | 2021-01-11 | |
| BAKER BROS. ADVISORS LP | director, 10 percent owner: | 2021-01-01 | 0 | 2021-01-11 | |
| Tasse Daniel | director, officer: Chief Executive Officer | 2021-01-01 | 36.71 | 2021-01-11 | |
| Tasse Daniel | director, officer: Chief Executive Officer | 2021-01-01 | 20.78 | 2021-01-11 | |
| Tasse Daniel | director, officer: Chief Executive Officer | 2021-01-01 | 5.09 | 2021-01-11 | |
| SOLAND DANIEL B | director | 2021-01-01 | 0 | 2021-01-11 | |
| SOLAND DANIEL B | director | 2018-05-16 | 45.54 | 2021-01-11 | |
| SOLAND DANIEL B | director | 2015-03-24 | 52.59 | 2021-01-11 | |
| SOLAND DANIEL B | director | 2015-11-19 | 80.79 | 2021-01-11 | |
| SOLAND DANIEL B | director | 2016-12-09 | 85.3 | 2021-01-11 | |
| Robitaille Sebastien | officer: Chief Financial Officer | 2021-01-01 | 0 | 2021-01-11 |